Table 5 Clinical characteristics of participants.
Characteristics | Case, n = 71 (54.2%) | Control, n = 60 (45.8%) | p-value |
|---|---|---|---|
Age (years) | 53.13 ± 6.58 | 53.49 ± 6.92 | 0.733 |
Hemoglobin | 11.36 ± 1.43 | 33.94 ± 167.80 | 0.259 |
WBCs | 7.23 ± 2.43 | 7.30 ± 0.82 | 0.833 |
PLTs | 312.34 ± 135.29 | 293.60 ± 86.33 | 0.357 |
Urea | 25.45 ± 6.70 | 16.33 ± 4.46 | < 0.001 |
Creatinine | 0.76 ± 0.19 | 0.69 ± 0.10 | 0.004 |
T. Bilirubin | 0.53 ± 0.26 | 0.76 ± 0.23 | < 0.001 |
ALT | 39.61 ± 41.68 | 23.43 ± 5.93 | 0.003 |
AST | 39.93 ± 34.27 | 23.80 ± 5.93 | < 0.001 |
ALP | 140.94 ± 80.82 | 111.90 ± 25.98 | 0.009 |
HER2, n (%) | < 0.001 | ||
0 | 36 (50.7) | 60 (100.0) | |
1 | 35 (49.3) | 0 (0.0) | |
ER, n (%) | < 0.001 | ||
0 | 26 (36.6) | 60 (100.0) | |
1 | 45 (63.4) | 0 (0.0) | |
PR, n (%) | < 0.001 | ||
0 | 32 (45.1) | 60 (100.0) | |
1 | 39 (54.9) | 0 (0.0) | |
TNBC, n (%) | 0.002 | ||
0 | 61 (85.9) | 60 (100.0) | |
1 | 10 (14.1) | 0 (0.0) | |
TPBC, n (%) | < 0.001 | ||
0 | 58 (81.7) | 60 (100.0) | |
1 | 13 (18.3) | 0 (0.0) | |
Haplogroup | < 0.001 | ||
M | 33 (46.5) | 13 (21.7) | |
U | 10 (14.1) | 31 (51.7) | |
Others | 28 (39.4) | 16 (26.7) | |
